Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Legembre

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
European Journal of Immunology|October 14, 2023
CD95L concatemers highlight different stoichiometries of CD95-mediated apoptotic and nonapoptotic pathwaysEden Lebrault, Christelle Oblet, Keerthi Kurma, et al.
Molecular and Cellular Biology|July 19, 2005
Amplification of Fas-mediated apoptosis in type II cells via microdomain recruitmentPatrick Legembre, Sophie Daburon, Patrick Moreau, et al.
Seminars in Cancer Biology|June 10, 2019
CD95/Fas and metastatic disease: What does not kill you makes you strongerJean Philippe Guégan, Christophe Ginestier, Emmanuelle Charafe-Jauffret, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2019
Probing the side chain tolerance for inhibitors of the CD95/PLCγ1 interactionHa Thanh Nguyen, Jean-Philippe Guégan, Daniel Best, et al.
Scientific Reports|June 16, 2016
The cleaved FAS ligand activates the Na(+)/H(+) exchanger NHE1 through Akt/ROCK1 to stimulate cell motilityMichael Monet, Mallorie Poët, Sébastien Tauzin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2003
Two CD95 tumor classes with different sensitivities to antitumor drugsAlicia Algeciras-Schimnich, Eric M Pietras, Bryan C Barnhart, et al.
BMC Research Notes|June 22, 2018
Tumor analysis: freeze-thawing cycle of triple-negative breast cancer cells alters tumor CD24/CD44 profiles and the percentage of tumor-infiltrating immune cellsMatthieu Le Gallo, Thibault de la Motte Rouge, Amanda Poissonnier, et al.
Leukemia Research and Treatment|December 6, 2012
Mycophenolic Acid overcomes imatinib and nilotinib resistance of chronic myeloid leukemia cells by apoptosis or a senescent-like cell cycle arrestClaire Drullion, Valérie Lagarde, Romain Gioia, et al.
European Journal of Immunology|May 11, 2011
Actin-independent exclusion of CD95 by PI3K/AKT signalling: implications for apoptosisMathieu Pizon, Hariniaina Rampanarivo, Sébastien Tauzin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signalBenjamin Chaigne-Delalande, Gwendaline Guidicelli, Lionel Couzi, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
European Journal of Immunology|October 14, 2023
CD95L concatemers highlight different stoichiometries of CD95-mediated apoptotic and nonapoptotic pathwaysEden Lebrault, Christelle Oblet, Keerthi Kurma, et al.
Molecular and Cellular Biology|July 19, 2005
Amplification of Fas-mediated apoptosis in type II cells via microdomain recruitmentPatrick Legembre, Sophie Daburon, Patrick Moreau, et al.
Seminars in Cancer Biology|June 10, 2019
CD95/Fas and metastatic disease: What does not kill you makes you strongerJean Philippe Guégan, Christophe Ginestier, Emmanuelle Charafe-Jauffret, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2019
Probing the side chain tolerance for inhibitors of the CD95/PLCγ1 interactionHa Thanh Nguyen, Jean-Philippe Guégan, Daniel Best, et al.
Scientific Reports|June 16, 2016
The cleaved FAS ligand activates the Na(+)/H(+) exchanger NHE1 through Akt/ROCK1 to stimulate cell motilityMichael Monet, Mallorie Poët, Sébastien Tauzin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2003
Two CD95 tumor classes with different sensitivities to antitumor drugsAlicia Algeciras-Schimnich, Eric M Pietras, Bryan C Barnhart, et al.
BMC Research Notes|June 22, 2018
Tumor analysis: freeze-thawing cycle of triple-negative breast cancer cells alters tumor CD24/CD44 profiles and the percentage of tumor-infiltrating immune cellsMatthieu Le Gallo, Thibault de la Motte Rouge, Amanda Poissonnier, et al.
Leukemia Research and Treatment|December 6, 2012
Mycophenolic Acid overcomes imatinib and nilotinib resistance of chronic myeloid leukemia cells by apoptosis or a senescent-like cell cycle arrestClaire Drullion, Valérie Lagarde, Romain Gioia, et al.
European Journal of Immunology|May 11, 2011
Actin-independent exclusion of CD95 by PI3K/AKT signalling: implications for apoptosisMathieu Pizon, Hariniaina Rampanarivo, Sébastien Tauzin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signalBenjamin Chaigne-Delalande, Gwendaline Guidicelli, Lionel Couzi, et al.
Pageof 9